KPIs & Operating Metrics(New)
Growth Metrics

Bristol Myers Squibb (BMY) Cash from Investing Activities Growth (5y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 1.74%
Dec 31, 2025 34.19%
Sep 30, 2025 -51.54%
Jun 30, 2025 -23.31%
Mar 31, 2025 -23.02%
Dec 31, 2024 56.21%
Sep 30, 2024 -19.59%
Jun 30, 2024 -30.91%
Mar 31, 2024 -82.97%
Dec 31, 2023 1.64%
Sep 30, 2023 -22.77%
Jun 30, 2023 1.12%
Mar 31, 2023 -37.33%
Dec 31, 2022 3.55%
Sep 30, 2022 -75.51%
Jun 30, 2022 22.35%
Mar 31, 2022 19.80%
Dec 31, 2021 90.46%
Sep 30, 2021 -21.54%
Jun 30, 2021 -15.01%
Mar 31, 2021 -16.00%
Dec 31, 2020 -64.39%
Sep 30, 2020 -28.00%
Jun 30, 2020 19.48%
Mar 31, 2020 -4.15%
Dec 31, 2019 -105.56%
Sep 30, 2019 24.52%
Jun 30, 2019 19.85%
Mar 31, 2019 -13.68%
Dec 31, 2018 -35.93%
Sep 30, 2018 20.91%
Jun 30, 2018 -51.97%
Mar 31, 2018 -17.79%
Dec 31, 2017 29.76%
Sep 30, 2017 15.26%
Jun 30, 2017 -45.54%
Mar 31, 2017 41.75%
Dec 31, 2016 -49.66%
Sep 30, 2016 -17.69%
Jun 30, 2016 26.37%
Mar 31, 2016 24.51%
Dec 31, 2015 16.87%
Sep 30, 2015 -15.61%
Jun 30, 2015 -49.14%
Mar 31, 2015 18.12%
Dec 31, 2014 18.55%
Sep 30, 2014 15.80%